´ëÇÑ°íÇ÷¾ÐÇÐȸ Á¦7ȸ Æó°íÇ÷¾Ð ¿¬·Ê Çмú´ëȸ(PH Korea 2022) : 2022-11-19±³À°ÀÏÀÚ : 2022-11-19
±³À°Àå¼Ò : ¼ÛµµÄÁº¥½Ã¾Æ
±³À°ÁÖÁ¦ :
´ëÇÑ°íÇ÷¾ÐÇÐȸ Á¦7ȸ Æó°íÇ÷¾Ð ¿¬·Ê Çмú´ëȸ(PH Korea 2022)ÁÖÃÖ±â°ü : ´ëÇÑ°íÇ÷¾ÐÇÐȸ
´ã´çÀÚ : Çö°æ¸²
¿¬¶ôó : 032-460-3663
À̸ÞÀÏ :
kphs.or@gmail.com ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
ÀÎõ±¤¿ª½Ã±³À°½Ã°£ : 6 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 10,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 09:00~09:15 Pulmonary hypertension classification case: CTD-PAH(Group 1) ¹éÀç¼÷(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 09:15~09:30 Pulmonary hypertension classification case: LHD-PH: IpcPH, CpcPH, and LVAD-PH(Group 2) À念¿ì(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 09:30~09:45 Pulmonary hypertension classification case: ILD-PH(Group 3) ÀåÇ×Á¦(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 09:45~10:00 Pulmonary hypertension classification case:CTEPH(Group 4) ¾Èö¹Î(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 10:00~10:15 Pulmonary hypertension classification case:Misc. Multifactorial-PH(Group 5) ÀÌÁÖÈñ(ÃæºÏÀÇ´ë)
Åä·Ð 11-19 ÇÁ¸®¹Ì¾îº¼·ë 10:15~10:35 Pulmonary hypertension classification case based learning ±è´ëÈñ(¿ï»êÀÇ´ë)
ÈÞ½Ä 11-19 ÇÁ¸®¹Ì¾îº¼·ë 10:35~10:55 ÈÞ½Ä ()
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 10:55~11:25 ESC-ERS 2022 Guideline Stephan Rosencranz(University of Cologne, Germany)
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 11:25~11:40 Lessons 2020 Korean PH guideline ¹ÚÀçÇü(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 11:40~11:55 Proposals for next Korean PH guideline ÃÖÁ¤Çö(ºÎ»êÀÇ´ë)
Åä·Ð 11-19 ÇÁ¸®¹Ì¾îº¼·ë 11:55~12:10 How to make New Korean PH Guideline? ³ªÁø¿À(°í·ÁÀÇ´ë)
½Ä»ç 11-19 ÇÁ¸®¹Ì¾îº¼·ë 12:10~13:10 ½Ä»ç ()
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 13:10~13:25 Update of PH incidence in Korea ÀüÂùÈ«(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 13:25~13:40 Update of insurance system for PH drugs in Korea Çϱâ¼ö(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 13:40~13:55 How to use new drug and devices for PH in Korea ±è±â¹ü(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 13:55~14:10 Government support for PH treatment in Japan Hiromi Matsubara(Okayama University Graduate School of Medicine, Japan)
Åä·Ð 11-19 ÇÁ¸®¹Ì¾îº¼·ë 14:10~14:25 Policy session for pulmonary hypertension treatment ±è°èÈÆ(Àü³²ÀÇ´ë)
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 14:25~14:40 South Korea_Muldisciplinary Approach for Better Outcome ¾È°æÁø(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 14:40~14:55 Japan_Muldisciplinary Approach for Better Outcome Yu Taniguchi(Kobe University)
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 14:55~15:10 China_Muldisciplinary Approach for Better Outcome Yu-Ping Zhou(Peking Union Medical College Hospital)
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 15:10~15:25 Taiwan (Genetic study for pulmonary arterial hypertension-central Taiwan study) Kae-woei Liang(China Medical University Hospital, Taiwan)
Åä·Ð 11-19 ÇÁ¸®¹Ì¾îº¼·ë 15:25~15:40 EASOPH session: Muldisciplinary Approach for Better Outcome Á¤ÁßÈ(Á¶¼±ÀÇ´ë)
ÈÞ½Ä 11-19 ÇÁ¸®¹Ì¾îº¼·ë 15:40~16:00 ÈÞ½Ä ()
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 16:00~16:15 Pediatric PH in Japan today Shouzaburoh Doi(Tokyo Medical and Dental University, Japan)
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 16:15~16:30 Biomarkers for PH diagnosis and grading ÀÌÀç½Â(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 16:30~16:45 Devices for G2 PH ÃÖÁø¿À(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 16:45~17:00 New trials for PH treatment ±è°æÈñ(ÀÎõ¼¼Á¾º´¿ø)
±³À°½Ã°£ 11-19 ÇÁ¸®¹Ì¾îº¼·ë 17:15~17:30 Intensive PAH treatment Hiromi Matsubara(Okayama Univ., Japan)
Åä·Ð 11-19 ÇÁ¸®¹Ì¾îº¼·ë 17:30~17:45 Update for pulmonary hypertension management ±èÁöÈñ(°¡Å縯ÀÇ´ë)